Your browser doesn't support javascript.
loading
A detox dilemma beyond benzodiazepines; clonidine's quandary in alcohol withdrawal management.
Johnson, Matthew; Cosentino, Danielle; Fuehrlein, Brian.
Affiliation
  • Johnson M; Department of Psychiatry, Yale University School of Medicine, New Haven, Connecticut, USA.
  • Cosentino D; Department of Psychiatry, West Haven VA Medical Center, West Haven, Connecticut, USA.
  • Fuehrlein B; Department of Psychiatry, West Haven VA Medical Center, West Haven, Connecticut, USA.
Am J Addict ; 2024 Aug 03.
Article in En | MEDLINE | ID: mdl-39096168
ABSTRACT
BACKGROUND AND

OBJECTIVES:

Benzodiazepines are the primary method of treatment of alcohol withdrawal, though the American Society of Addiction Medicine guidelines also include alternative agents for consideration. Observations in a Department of Veterans Affairs (VA) psychiatric emergency room noted consistent benzodiazepine use with an overall lack of use of alternative agents, even with low Clinical Institute Withdrawal Assessment for Alcohol (CIWA) scores and in the absence of other concerning symptoms. Due to concerns of potential more-than-necessary benzodiazepine use, we analyzed adjunctive clonidine use for elevated blood pressure/pulse in alcohol withdrawal among this Veteran population.

METHODS:

This is a single-site VA retrospective chart review of the psychiatric emergency room from July 1, 2022, to June 30, 2023, focused on patients with alcohol withdrawal managed on a CIWA protocol. Excluding concurrent opioid withdrawal and clonidine as home medication, 167 patient charts were analyzed for this study.

RESULTS:

Among 167 patients, 99 (59.3%) had comorbid hypertension. A total of 614 medication doses were given for elevated CIWA (373, 60.8%) and elevated blood pressure/pulse (241, 39.2%). Of the 241 doses for elevated blood pressure/pulse, only 2.5% were clonidine. Among all benzodiazepine doses, 75.3% were given to patients with comorbid hypertension. Clonidine was administered to 3.0% of patients, making up 2.5% of total dosing. DISCUSSION AND

CONCLUSIONS:

Alcohol withdrawal management lacks optimization. Integrating adjunctive medications could reduce potential benzodiazepine overuse effectively addressing elevated blood pressure/pulse. SCIENTIFIC

SIGNIFICANCE:

This study sheds light on the potential underutilization of clonidine and its potential role in improving alcohol withdrawal syndrome management. By addressing elevated blood pressure/pulse and curbing potential overuse of benzodiazepines, it may contribute to further optimizing patient care.

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Am J Addict Journal subject: TRANSTORNOS RELACIONADOS COM SUBSTANCIAS Year: 2024 Document type: Article Affiliation country:

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Am J Addict Journal subject: TRANSTORNOS RELACIONADOS COM SUBSTANCIAS Year: 2024 Document type: Article Affiliation country: